Match Document Document Title
DE102005054206A1 Method for automatic processing of pooled sample for testing donated blood and blood products, by combining the samples to sample pool, addition of solution to the enriched sample pool and resuspension of the sample pool in the solution  
The method for automatic processing of pooled blood sample for testing donated blood and blood products by nucleic acid amplification techniques, comprises combining (pooling) of the samples to a...
DE102006001081A1 New isolated nucleic acid, useful as source of primers for selective detection, in plants and soil, of the AG1-IB subgroup of Rhizoctonia solani  
An isolated nucleic acid (I), and its fragments, complements, homologs and variants are new. New isolated nucleic acid (I) is: (A) Seq. (1) of 1547 nt, or especially its fragments Seq. (2)-(132),...
DE102006057975B4 Method and device for detection of microorganisms and / or their activity  
A method for detecting microorganisms and / or their activity with biosensors, characterized in that in regions, at least one ligand to the binding of a receptor or at least one receptor for a...
DE102006057975A1 Detection of microorganisms and/or their activity by biosensors, by immobilizing ligands for binding a receptor at a substrate surface or immobilizing the receptor for the ligands at the surface in chemical-, physical- or biological manner  
The detection of microorganisms and/or their activity using biosensors, comprises area-wise immobilization of signal molecule ligands for binding a receptor at a surface of a substrate (1) or...
DE102005050691A1 Differentiating patients with aggressive disease against mild progressive disease comprises measuring expression of major histocompatibility class molecule of myeloid cell and correlating the expression level with progression disease  
Method for differentiating patients with an aggressive disease against patients with a mild progressive disease comprises measuring the expression of major histocompatibility (MHC) class (II)...
DE102005056561A1 Analyzing the bio-degradability of material, preferably waste, comprises adding bacterial culture to degrade the material, absorbing gas obtained from the process, and adding biodegradable additive to determine unwanted material content  
Procedure to analyze the bio-degradability of a material, particularly a waste, comprises adding a bacterial culture to degrade the material, absorbing a gas obtained from the decomposition...
DE102005052957A1 Process for the selective enrichment of particle-bound biomolecules or bioparticles  
process for selective particle-bound enrichment of biomolecules or Bioparticles by the use of at least two different Binding methods.
DE102005052384A1 Diagnosis, labeling and treatment of lung tumors, using substances with affinity for specific genes whose expression is altered in tumors or for their derived products  
Method for diagnosis, labeling and treatment of lung tumors in which a biological or biotechnical system is contacted with at least one substance (X), at least partly dissolved and having affinity...
DE102005052384B4 Method for detecting, marking and treatment of epithelial lung tumor cells as well as means for performing the method  
Method for detecting, marking and treatment of epithelial lung tumor cells from large cell carcinomas, squamous cell carcinomas and adenocarcinomas, characterized in that a biological or...
DE102005049800B4 A method for identifying inhibitors of Epstein-Barr virus induced gene 3 (EBI 3) and their uses in the treatment of metastatic tumors and allergic asthma  
A method for identifying inhibitors of the Epstein-Barr virus-induced gene 3 (EBI3), comprising the steps of: a) providing a test system comprising EBI3 or a biologically active fragment or...
DE102005049800A1 A method for identifying inhibitors of Epstein-Barr virus induced gene 3 (EBI 3) and their uses in the treatment of metastatic tumors and allergic asthma  
The This invention relates to a method for the detection of Inhibitors of Epstein-Barr virus induced gene 3 (EBI3), a A process for preparing a pharmaceutical composition, comprising an inhibitor,...
DE102005050557A1 SRF as a diagnostic and / or therapeutic target for diseases associated with neuronal abnormalities  
The Invention relates to the use of at least one substance for Detection and / or for influencing the expression and / or activity of SRF (Serum response factor) and / or SRF-regulated...
DE102005047384A1 Chip for diagnosis of Candida in clinical material, comprises a carrier with a microstructured surface that includes recognition spots for thiol-specific antioxidant protein and antibodies against it  
Candidadiagnostic chip (A) comprises a carrier (C) having on at least one surface a microstructure that includes immobilized, molecule-specific recognition spots containing (i) specific antibodies...
DE102005045642B4 Inorganic marking particles on the basis of natural microorganisms for the identification of products to their originality and detection process for preparing  
Inorganic Marking particles on the basis of natural microorganisms with a specific individuality in terms of surface and properties for detectable labeling of products with a known original...
DE102005045642A1 Inorganic marking particles for the identification of products to their tamper evident, methods for making and using  
Known inorganic marking particles having a specific surface with respect individuality and Properties for detectable labeling of products with a known original information to the tamper evident...
DE102005038737B4 Zytotoxizitätstestverfahren  
Zytotoxizitätstestverfahren for the quantitative determination of the concentration of a substance toxic cultured using on a support (10) test organisms (30) marked by Applying at least one...
DE102005038737A1 Cytotoxicity test using test cyanobacteria cultivated on a substrate, by applying dissolved substances in a solvent at a place of the substrate, evaporating the solvent, spraying the bacteria on the substrate, and cultivating the bacteria  
The cytotoxicity test using test cyanobacteria (30) cultivated on silica gel substrate (10), includes applying a dissolved test substances (20A, 20B) in a solvent at a place of the substrate,...
DE102005036658A1 Identifying inhibitors of platelet-activation factor receptors, useful for treatment of e.g. arteriosclerosis and plaque instability, by stimulating cells that express the receptor in presence of test compounds  
Method for identifying inhibitors (A) of platelet-activation factor receptors (PAFR) in which a cell or cell line that expresses PAFR is stimulated with PAFR agonist and incubated with candidate...
DE102005033474A1 Investigating tissue samples, especially for cancer diagnosis, comprises assigning fluorescence-labeled samples to positional coordinates, irradiating the samples and determining the fluorescence intensity  
Investigating tissue samples starting with a set of tissue samples treated with a systemically applicable fluorescent marker comprising assigning the samples to the xy coordinates of a particular...
DE102006031200A1 A method for calculating the biodegradation of hydrocarbons trapped in a geological structure  
process to calculate the biodegradation of in a geologic structure trapped hydrocarbons due to the activity of a Bacterial population- Starting from data that the physical and geometric parameters...
DE102005020754B3 Cellular assay method for identifying PKCtheta inhibitors  
The Invention relates to a method to study the modulating Effect of a test substance to a PKCΘ-dependent signal transduction pathway or for locating a PKCΘ modulator in a human or animal cell,...
DE102005030552A1 Selection of phosphatase activity  
The This invention relates to methods for the selection of nucleic acid molecules encoding for proteins with phosphatase activity, from a bank to be examined nucleic acid molecules.
DE102005030552B4 Selection of phosphatase activity  
A method for selecting a nucleic acid molecule coding for a selected phosphatase activity from a group of nucleic acid molecules to be examined, comprising the steps of: a) providing the nucleic...
DE102005027796A1 Detection of an active substance for killing of murine fibrosarcoma tumor cells by releasing apoptosis effectors, comprises adding a catalase inhibitor and detecting catalase activity and apoptotis cells  
Detection of an active substance for killing of murine fibrosarcoma tumor cells by releasing apoptosis effectors, sample preparations are arranged in cell culture medium in a separate culture...
DE102005027796B4 Method of finding an active ingredient, which allows killing of tumor cells in a tumor disease of a mammal or human  
process for finding an active ingredient, which is a killing of tumor cells by inducing Apoptosis by an effector in a tumor disease of a mammal or allows people with the following steps: a1)...
DE10113042B4 HIV inhibitor screening system  
process to identify compounds which block the interaction of the gp120 protein HIV or parts thereof with the co-receptor CXCR4, CCR5 and / or another 7-helix transmembrane receptor for HIV...
DE102005026710A1 Method for testing substances or substance mixtures, its use and corresponding analysis kit  
The This invention relates to a method for testing substances and mixtures of substances for toxic characteristics, its use and corresponding analysis kits. The method is essentially based on the...
DE102005021205A1 Detection of vitality of living cells in cell culture or tissue by nicotinamide adenine dinucleotide hydrogenase fluorescence spectroscopy, comprises irradiating the cells by short periodically produced light pulses in the near ultraviolet  
The detection of vitality of living cells (3) in cell culture or tissue, comprises irradiating the cells by short periodically produced light pulses in a near ultraviolet. The spectral light is...
DE102005021205B4 Method and arrangement for local detection of the vitality of living cells in cell cultures or in tissue  
process to the local detection of the viability of live cells in cell cultures or in tissue by means of NADH fluorescence spectroscopy, thereby in that a special optical measuring head for...
DE102006021267A1 Glucocorticoid receptor ligand transactivation and transrepression activity characterizing method for primary immune cell, involves verifying regulation of expression of gene for determining transrepression and transactivation of ligand  
The method involves expositing a primary immune cell with a glucocorticoid receptor (GR) ligand, and verifying regulation of expression of a GR-sensitive gene for determining the transrepression...
DE102005019653A1 Plant extracts against halitosis, gingivitis or periodontitis  
The present invention relates to plant extracts to inhibit enzymes, especially for inhibiting the methionine gamma lyase (METase), and / or for the prevention or treatment of halitosis or...
DE102005019441A1 Method for determining oxidative stress potential of test compounds, useful for assessing potential toxicity of food ingredients and antioxidant capacity  
Method for determining the oxidative stress potential (OSP) of a test substance (I) comprises incubating (I) with at least one dye (II) in presence of living cells and drawing conclusions about...
DE102006015680A1 Blood test method, nucleic acid extraction methods and nucleic acid extraction apparatus  
According to the invention a Procedures provided that the extraction of both a liquid sample for a biochemical examination and an immunological test and a Blood cell sample for a nucleic acid test...
DE102006009709A1 Method for detecting microorganisms without a culturing step, useful particularly for detecting potential germ warfare agents, uses a cantilever coated with specific binding material for the target organism  
Method for detecting a microorganism or bacterium (A) without culture comprises (a) preparing a cantilever or spring beam with a coating that contains bacteriophage particles, or derived proteins...
DE102005013712A1 Apparatus used for assessing substances for their activity by cell-biological testing, comprises that it forms mixtures of two substances with a concentration gradient  
In test apparatus (1) mixtures of two substances are formed and the activity of the mixtures is determined by cell-biological testing, the metal or plastic test device is set down on a polymer...
DE10020704B4 Biochip for archiving and medical laboratory analysis of biological sample material, process for its preparation and its use in diagnostic procedures  
biochip for diagnostic Purposes and for archiving biological samples, which a sample carrier comprises of a solid matrix to whose under structured into micro areas surface sample material to be...
DE10152376B4 Fluorescent phospholipase A2-samples and their membrane-permeable derivatives  
Phospholipasesubstrat of the general formula I wherein each A independently an alkylene or alkenylene group, branched or unbranched, having 1 to 20 carbon atoms, R1 and R2 each a different...
DE10056338B4 Method and apparatus for treating a medium with microorganisms  
process for the treatment of a medium with microorganisms which comprises the steps comprising: a) introducing micro-organisms from a bioreactor in the medium to be treated, b) measuring a...
DE102005027906B4 Procedures for the timely detection and prediction of the state of development of cell suspensions and / or to optimize and control of biotechnological processes  
The destructive process of the invention allows detection of previously unknown by cyclical course of the polarizability tensor rapid determination of specific growth criteria, cell activities and...
DE102005027906A1 Procedures for the timely detection and prediction of the state of development of cell suspensions and / or to optimize and control of biotechnological processes  
The inventive destructive The method allows detection of previously unknown by cyclic Course of the polarizability tensor rapid determination of specific growth criteria, cell activities and...
DE102004063265B4 A method for determining the function of nucleic acid sequences and the expression products encoded thereby  
A method for studying the function of a nucleic acid and / or a nucleic acid expression product in an organism, comprising the steps of: (A) introduction of RNA derived from the nucleic acid and /...
DE102004063265A1 A method for determining the function of nucleic acid sequences and the expression products encoded thereby  
The Invention relates to methods for the examination and determination of Function of nucleic acid sequences and nucleic acid expression products by introduction of RNA in host cells.
DE102004062273A1 Detecting agonists of insect calcium ion channels, useful potentially as insecticides, by measuring their effect on recombinant cells that express the channel and calcium-sensitive luciferase-binding protein  
Detecting an agent (I) that activates an insect calcium ion channel (A) regulated by cyclic nucleotides, is new. Detecting an agent (I) that activates an insect calcium ion channel (A) regulated...
DE20023799U1 Detecting infections by acid-resistant microorganisms, particularly for diagnosing Helicobacter pylori, comprises immunochromatographic detection of antigen in feces  
Detecting infection by an acid-resistant microorganism (A), in a mammal, comprises using immunochromatography. Detecting infection by an acid-resistant microorganism (A), in a mammal, comprises...
DE102004061903A1 New isolated polynucleotide based on gene isolated from Heliothis virescens, encoding insect neurokinin receptor, useful as target in screening for receptor modulating pesticides  
An isolated insect polynucleotide (I) encoding insect neurokinin receptor, is new : An isolated insect polynucleotide (I) encoding insect neurokinin receptor, is new (I) comprises a nucleotide...
DE102004061289B4 A test kit with test cells and immune cells, and manufacturing method thereof  
test kit with test cells and with antigen-presenting cells and immunological Effector cells from the same donor, for in vitro investigation of Action of effectors on the test cells, said test...
DE102004061289A1 Test kit for in vitro studies of effector action, e.g. for testing toxicity and/or allergenicity of topical agents, comprises test cells, cultured in vitro or recovered ex vivo, and immune cells  
A new test kit (A) with test cells and immune cells, for in vitro studies of the action of effectors (I) (specifically physical, biological and/or chemical effectors) on the test cells, where the...
DE10150971B4 Method and apparatus for the measurement of receptor activity in transfected cells  
process for the measurement of receptor activity of transfected cells, in which by means of a capacitive arrangement transfected from substrate (1), insulating layer (2) and cell layer from whole...
DE102004059925A1 Visualization and inhibition of intracellular protein activity comprises binding the domain for the protein molecules and oligomerizing the valences of the molecules in their active form  
Visualization and inhibition of intracellular protein activity comprises visualizing proteins by confocal fluorescence-microscopy, where probes with the same and different valences of the...
DE102004056794A1 Protein biochip for validation of binders  
The present invention relates to an assembly of proteins containing at least a cDNA expression library and its use as protein biochip, especially for validation of binders and Protein binders, and...